APA (7th ed.) Citation

GL, C., SB, H., SC, Y., JM, M., BJ, O., J, C., . . . HC, M. (2013). Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nature genetics, 45(7), 825. https://doi.org/10.1038/ng.2646

Chicago Style (17th ed.) Citation

GL, Carvill, et al. "Targeted Resequencing in Epileptic Encephalopathies Identifies De Novo Mutations in CHD2 and SYNGAP1." Nature Genetics 45, no. 7 (2013): 825. https://doi.org/10.1038/ng.2646.

MLA (9th ed.) Citation

GL, Carvill, et al. "Targeted Resequencing in Epileptic Encephalopathies Identifies De Novo Mutations in CHD2 and SYNGAP1." Nature Genetics, vol. 45, no. 7, 2013, p. 825, https://doi.org/10.1038/ng.2646.